Incyte Corporation (INCY)
Debt-to-assets ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 5,444,320 | 6,782,110 | 5,840,980 | 4,933,350 | 3,560,920 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $5,444,320K
= 0.00
The debt-to-assets ratio for Incyte Corporation has consistently remained at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not used any debt to finance its assets during this period. A debt-to-assets ratio of 0.00 typically suggests that the company relies on equity financing rather than debt to fund its operations and investments. Incyte Corporation's strong financial position and low reliance on debt may indicate a conservative financing strategy and lower financial risk compared to companies with higher debt levels.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-assets ratio
Incyte Corporation
INCY
0.00
Arrowhead Pharmaceuticals Inc
ARWR
0.34
Charles River Laboratories
CRL
0.00
Exelixis Inc
EXEL
0.00
IQVIA Holdings Inc
IQV
0.48
Medpace Holdings Inc
MEDP
0.00